Clinical Trials on Flavivirus Infection in Finland

Total 1375 results

Koite Health Oy
University of Helsinki; Tampere University

Completed

Impact of Regular Home Use of Lumoral Dual-light Photodynamic Therapy on Plaque Control and Gingival Health

Periodontitis | Plaque Induced Gingivitis | Plaque, Dental

Finland
Thrombologic ApS
Rigshospitalet, Denmark; Anders Perner

Terminated

Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis

Pneumonia

Finland, Denmark
Tampere University
Oulu University Hospital; Kuopio University Hospital; Tampere University Hospital and other collaborators

Recruiting

Comparing the Efficacy of Two Valved Holding Chambers in Acute Wheezing (CHAMBER)

Bronchospasm; Bronchitis | Bronchitis Obstructive | Bronchiolitis; Obstruction

Finland
GlaxoSmithKline

Active, not recruiting

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline's Herpes Zoster Subunit Vaccine (HZ/su) When Given on a Two-dose Schedule to Adults at Least 50 Years of Age (YOA) Who Had Prior Episode of Shingles

Herpes Zoster

Spain, Panama, Mexico, Russian Federation, Finland, Estonia, Hong Kong, United Kingdom
GlaxoSmithKline

Completed

Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK134612

Infections, Meningococcal

Finland
FibroGen

Terminated

A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection

Liver Fibrosis Due to Chronic Hepatitis B Infection

Hong Kong, Thailand
University of Turku

Recruiting

TROPOnin FRAGMentation in Myocardial Injury Study (Tropo-Fragm)

Myocardial Injury | Acute Myocardial Infarction Type 1

Finland, Switzerland
Jukka Putaala

Recruiting

Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke (CARDIOSTROKE)

Hypertension | Ischemic Stroke | Atrial Fibrillation | Transient Ischemic Attack | Empowerment

Finland
National Institute of Allergy and Infectious Diseases...

Terminated

Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS)

Urinary Tract Infection

United States
Helsinki University Central Hospital
University Hospital Inselspital, Berne

Completed

Targeted Tissue Perfusion Versus Macrocirculatory-guided Standard Care in Patients With Septic Shock (TARTARE-2S)

Critical Illness | Shock; Septic

Finland, Switzerland
Meridian Bioscience, Inc.

Completed

Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori

Helicobacter Pylori Infection

United States
GlaxoSmithKline

Completed

Long-term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bio's HRV Vaccine.

Infections, Rotavirus

Finland
Duke University
Antibacterial Resistance Leadership Group

Completed

A Rapid Test for Acute Respiratory Illness (Radical)

Bacterial Infections | Virus Disease | Respiratory Tract Infection Acute | Transcriptome

United States
Turku University Hospital
Vifor Pharma

Recruiting

Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery (PREFER-CABG)

Coronary Artery Disease | Postoperative Complications | Aortic Valve Stenosis | Aortic Aneurysm, Thoracic | Mitral Valve Disease

Finland
Tampere University
VTT Technical Research Centre of Finland; Tays Heart Hospital; GE Healthcare... and other collaborators

Completed

Arrhythmias in Post-Myocardial Infarction Patients

Myocardial Infarction | Coronary Artery Disease | Atrial Fibrillation | Ventricular Fibrillation | Ventricular Tachycardia | Atrioventricular Block | Atrial Flutter | Ventricular Arrythmia | Arrythmia | ECG Electrical Alternans

Finland
Helsinki University Central Hospital

Active, not recruiting

Aggravated Airway Inflammation: Research on Genomics and Optimal Operative Treatment (AirGOs Operative)

Asthma | Nasal Polyps | Aspirin Sensitivity | Sinusitis, Chronic

Finland, Netherlands
ViiV Healthcare
GlaxoSmithKline; Shionogi

Completed

A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive Subjects

Infection, Human Immunodeficiency Virus

United States
Danisco

Completed

The Effect of a Bifidobacterium and Polydextrose on Body Fat Mass (MetSProb)

Hyperglycemia | Obesity | Insulin Resistance

Finland
Oulu University Hospital

Unknown

Effect of the Nasal Provocation on the Breathing Style

Birch Pollen Allergy | Healthy Control Subjects

Finland
Finnish Institute of Occupational Health
The Social Insurance Institution of Finland; the Hospital District of Helsinki...

Active, not recruiting

Web-based Rehabilitation for Persistent Physical Symptoms. (DigiPimo)

Chronic Fatigue Syndrome | Persistent Physical Symptoms | Indoor Environment Associated Symptoms | Indoor Air Associated Symptoms

Finland
Tampere University Hospital

Recruiting

Toe Amputations in Patients With Diabetes (PANDORAT)

Infections | Diabetic Foot | Amputation

Finland
Sanofi Pasteur, a Sanofi Company

Completed

Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination

Virus Diseases | Bacterial Infections | Neisseria Meningitidis

Finland
Merck Sharp & Dohme LLC

Completed

The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection

HIV Infections

United States, Canada
National Institute of Allergy and Infectious Diseases...

Completed

Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

HIV Infection | Hepatitis C Infection

United States, Puerto Rico
Sanofi Pasteur, a Sanofi Company

Completed

Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants

Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type b

Finland, Sweden
Kanta-Häme Central Hospital
Linnan Klinikka Oy; Finnish Red Cross Blood Service; MTT Agrifood Research Finland

Completed

Hämeenlinna Metabolic Syndrome Research Program: Effects of Rapeseed Oil on Serum Lipids and Platelet Function (HMS-03)

Metabolic Syndrome

Finland
Kuopio University Hospital

Completed

Implementation of 23 Hour Surgery Model in a Tertiary Hospital (Herko)

Ovarian Cysts | Shoulder Impingement Syndrome | Appendicitis | Cholecystolithiasis | Laparoscopy | Ambulatory Surgical Procedures | Neurosurgery | Ambulatory Surgery | Gynecologic Surgical Procedures

Finland
Glaxo Wellcome

Completed

A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients

HIV Infections | Herpes Simplex

United States
Mitsubishi Tanabe Pharma Corporation

Completed

Safety and Pharmacokinetics of MCI-186 in Subjects With Acute Ischemic Stroke

Acute Ischemic Stroke (AIS)

Netherlands, Finland, United Kingdom
GlaxoSmithKline

Completed

Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A

Streptococcus Pneumoniae | Infections, Streptococcal

Finland
University of Pennsylvania
National Institute of Mental Health (NIMH)

Completed

HIV and STD Prevention for High-Risk, Inner-City, African American Youth

HIV Infections | Sexually Transmitted Diseases

United States
Solvay Pharmaceuticals

Terminated

Immunogenicity and Safety of Two Adjuvant Formulations of an Egg-Derived Pandemic Vaccine

Healthy Subjects

Finland, Germany
Helsinki University Central Hospital

Recruiting

Patient-reported Outcome Measures (PROMs) in Patients With Bodily Stress Syndrome: Protocol for a Prospective Cohort Study (SYMPA)

Fatigue | Irritable Bowel Syndrome | Fibromyalgia | Dysphagia | Chronic Fatigue Syndrome | Somatic Symptom | Exhaustion; Syndrome

Finland
Natural Resources Institute Finland
Tampere University

Active, not recruiting

Biodiversity Interventions for Assisted Living Centers (BIWE)

Autism Spectrum Disorder | Microbial Colonization | Visual Impairment | Immune System and Related Disorders | Nature, Human | Well-Being, Psychological

Finland
Helsinki University Central Hospital
Central Finland Central Hospital

Completed

Non-interventional Follow-up Versus Fluid Bolus in RESPONSE to Oliguria in the Critically Ill (RESPONSE)

Sepsis | Acute Kidney Injury | Critically Ill | Oliguria

Finland
Neuroscience Trials Australia
National Health and Medical Research Council, Australia; Monash University

Active, not recruiting

Trial of EXenatide in Acute Ischaemic Stroke (TEXAIS)

Acute Ischemic Stroke

Australia, Finland, New Zealand
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly

Influenza | Orthomyxoviridae Infection | Myxovirus Infection

United States
GlaxoSmithKline

Completed

Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals' Diphtheria, Tetanus and Pertussis Vaccine (Boostrix®) in Adults Aged 50 Years and Older

Herpes Zoster

United States
Javier P. Gisbert

Recruiting

European Registry on the Management of Helicobacter Pylori Infection

H. Pylori Infection

Switzerland, France, Serbia, Latvia, Estonia, Austria, Belgium, Bulgaria, Croatia, Czechia, Denmark, Finland, Germany, Greece, Hungary, Ireland, Italy, Lithuania, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slovenia and more
Durata Therapeutics Inc., an affiliate of Allergan...

Completed

Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Abscess | Cellulitis | Surgical Site Infection | Wound Infection

United States, Ukraine, Canada, Croatia, Georgia, Germany, Poland, Russian Federation
Helsinki University Central Hospital
Finnish Cultural Foundation; Orion Corporation, Orion Pharma; Finnish Foundation... and other collaborators

Completed

Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial (OXI)

Myocardial Infarction | Cardiovascular Diseases | Inflammation | Acute Coronary Syndrome | Hydroxychloroquine | Antirheumatic Agents

Finland
Kuopio University Hospital
Medical University of Vienna; Rigshospitalet, Denmark; University College, London and other collaborators

Active, not recruiting

Adenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for Treatment of Refractory Angina Pectoris (ReGenHeart)

Coronary Artery Disease | Refractory Angina Pectoris | Gene Transfer

Denmark, Finland
Herlev Hospital

Completed

Lactic Acid in the Rectum and Life-Threatening Infection

Septic Shock

Denmark, Finland
Genticel

Completed

Phase II Study of HPV Therapeutic Vaccine in HPV Infected Women With Normal Cytology or ASCUS/LSIL (RHEIA-VAC)

Genital Infection Viral | HUMAN PAPILLOMA VIRUS

Belgium, Spain, Finland, France, United Kingdom, Germany, Netherlands
University of Helsinki

Unknown

Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008

Food Hypersensitivity | Asthma | Atopic Dermatitis | Allergic Conjunctivitis | Allergic Rhinitis, Seasonal

Finland
Sanofi Pasteur, a Sanofi Company

Completed

A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 Months

Influenza | Swine-origin A/H1N1 Influenza

Finland
National Institute of Allergy and Infectious Diseases...

Completed

Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women

HIV Infections

United States, Puerto Rico, Brazil
Sanofi Pasteur, a Sanofi Company

Completed

Influenza Vaccine Revaccination in Ambulatory Elderly Subjects

Influenza | Myxovirus Infection | Orthomyxovirus Infection

United States
Finch Research and Development LLC.

Completed

Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff (PRISM3)

Clostridium Difficile Infection Recurrence

Canada, United States
GlaxoSmithKline

Completed

Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in Adolescents

Infections, Meningococcal

Finland, Poland

Clinical Trials on Flavivirus Infection in Finland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations